Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Study of Maintenance Therapy With Immunomodulator MGN1703 in Patients With Extensive Disease Small Cell Lung Cancer After Platinum-Based First-Line Therapy

NCT02200081 is registered in ClinicalTrials.gov with Mologen AG as lead sponsor.

NCT NCT02200081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02200081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Study of Maintenance Therapy With Immunomodulator MGN1703 in Patients With Extensive Disease Small Cell Lung Cancer After Platinum-Based First-Line Therapy
Lead sponsor
Mologen AG
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2014
Completion date
October 5, 2017
Enrollment
103 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer